
Ototoxicity-induced c-Fos activation underlies the regenerative capacity of the vestibular sensory epithelia
简介:
- 作者: Yunzhong Zhang, Dan You, Chenhao Che, Xinyuan Wang, Huawei Li, Yi-Quan Tang, Shan Sun
- 杂志: Cell Communication and Signaling
- Doi: https://www.doi.org/10.1186/s12964-025-02446-y
- 出版日期: 2025/10/8
摘要
The mammalian inner ear exhibits a striking dichotomy in regenerative capacity: while vestibular hair cells retain limited ability to regenerate, cochlear hair cells permanently lose this potential after birth. Exploiting this disparity, we employed single-cell comparative transcriptomics combined with lineage tracing to identify c-Fos as a critical early responder selectively activated in the vestibular epithelium following ototoxic injury. Transcriptomic and chromatin profiling revealed that c-Fos initiates regenerative reprogramming by transcriptionally priming Atoh1, the master regulator of hair cell fate, while synergizing with the Wnt and Notch pathways to balance progenitor proliferation and trans-differentiation. Functional validation showed that c-Fos overexpression significantly promoted vestibular hair cell regeneration and restored balance function in adult mice. Our findings establish c-Fos as a molecular switch bridging acute injury responses to tissue repair and highlight its potential as a therapeutic target for vestibular rehabilitation.
关于派真
作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IIT、IND及BLA的各个阶段。
凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。
